Nixon Peabody Trust Co. Boosts Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Nixon Peabody Trust Co. raised its position in The Procter & Gamble Company (NYSE:PGFree Report) by 3.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 102,217 shares of the company’s stock after buying an additional 3,857 shares during the period. Procter & Gamble accounts for 1.5% of Nixon Peabody Trust Co.’s investment portfolio, making the stock its 22nd biggest holding. Nixon Peabody Trust Co.’s holdings in Procter & Gamble were worth $16,585,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Advantage Trust Co purchased a new stake in shares of Procter & Gamble in the fourth quarter worth about $28,000. Naples Money Management LLC purchased a new position in Procter & Gamble during the fourth quarter worth about $29,000. Transcendent Capital Group LLC bought a new position in Procter & Gamble in the 4th quarter worth about $31,000. Ruedi Wealth Management Inc. boosted its position in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares during the last quarter. Finally, Criterion Capital Advisors LLC bought a new position in shares of Procter & Gamble in the fourth quarter worth approximately $33,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

PG stock traded down $1.27 during midday trading on Monday, reaching $165.34. The stock had a trading volume of 3,509,858 shares, compared to its average volume of 6,485,054. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $169.41. The stock has a market cap of $390.23 billion, a PE ratio of 27.06, a P/E/G ratio of 3.20 and a beta of 0.41. The firm has a fifty day simple moving average of $166.11 and a two-hundred day simple moving average of $160.29.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.43 billion. During the same quarter last year, the firm earned $1.37 earnings per share. The business’s revenue for the quarter was up .6% on a year-over-year basis. As a group, equities research analysts anticipate that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a dividend of $1.0065 per share. The ex-dividend date is Friday, July 19th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.43%. Procter & Gamble’s payout ratio is currently 65.85%.

Wall Street Analyst Weigh In

PG has been the subject of several research analyst reports. Citigroup lifted their target price on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a research report on Monday, April 22nd. StockNews.com upgraded Procter & Gamble from a “hold” rating to a “buy” rating in a research report on Tuesday, June 25th. Argus upped their price objective on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Finally, Jefferies Financial Group raised their price objective on Procter & Gamble from $175.00 to $182.00 and gave the company a “buy” rating in a report on Monday, April 22nd. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $171.74.

Check Out Our Latest Research Report on Procter & Gamble

Insider Buying and Selling at Procter & Gamble

In other news, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the completion of the transaction, the chief executive officer now owns 4,004 shares of the company’s stock, valued at $634,634. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, CEO Sundar G. Raman sold 31,924 shares of Procter & Gamble stock in a transaction on Monday, May 20th. The shares were sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the completion of the sale, the chief executive officer now directly owns 19,042 shares of the company’s stock, valued at approximately $3,179,061.90. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the completion of the sale, the chief executive officer now owns 4,004 shares in the company, valued at $634,634. The disclosure for this sale can be found here. Insiders have sold a total of 154,544 shares of company stock valued at $25,413,051 over the last quarter. 0.17% of the stock is owned by company insiders.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.